00-821-025
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 5mg | ￥ ůȂȂſȂȂ | -- | -- | -- | -- | -- | -- | ￥ ůȂȂſȂȂ | - + |
| 10mg | ￥ ŤȂȂſȂȂ | -- | -- | -- | -- | -- | -- | ￥ ŤȂȂſȂȂ | - + |
| 50mg | ￥ œůȂȂſȂȂ | -- | -- | -- | -- | -- | -- | ￥ œůȂȂſȂȂ | - + |
| 100mg | ￥ ƧůȂȂſȂȂ | -- | -- | -- | -- | -- | -- | ￥ ƧůȂȂſȂȂ | - + |
| 250mg | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 500mg | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
| 1g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
168.33
[1]. Chauhan D, et al. In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN908 against multiple myeloma cells. Clin Cancer Res. 20 Aug 15;1(16):53-21.
[2]. Kupperman E, et al. Evaluation of the proteasome inhibitor MLN908 in preclinical models of human cancer. Cancer Res. 2010 Mar 1;0(5):190-80.
[3]. Liu R, et al. A New Perspective for Osteosarcoma Therapy: Proteasome Inhibition by MLN908/2238 Successfully Induces Apoptosis and Cell Cycle Arrest and Attenuates the Invasion Ability of Osteosarcoma Cells in Vitro. Cell Physiol Biochem. 201 Jan 2;1(2
P261-P26-P20-P21-P280-P302+P352-P30+P30-P305+P351+P338-P330-P362+P36-P03+P233-P05-P501
GHS0
1985225 货期咨询
19898 货期咨询
192262 货期咨询
19221 货期咨询
192235 货期咨询
192233 货期咨询
19223 货期咨询
16000 货期咨询
沪ICP备101965号
